In Korean patients with BMAD, 22.9% had P/LP ARMC5 variants, associated with larger tumor size and significantly higher cortisol levels (153.1 vs 100.6 ng/mL).
Are pathogenic ARMC5 variants associated with specific clinical, radiological, and steroidogenic phenotypes in Korean patients with bilateral macronodular adrenocortical disease?
In Korean patients with bilateral macronodular adrenocortical disease, pathogenic ARMC5 variants are present in about 23% of cases and correlate with more severe radiological and steroidogenic features.
Tasa de eventos absoluta: 0% vs 0%
Abstract Objective Bilateral macronodular adrenocortical disease (BMAD) is a rare disorder characterized by bilateral adrenocortical nodules and variable cortisol excess. ARMC5 is a well-established genetic driver of BMAD, but data in East Asian populations are limited. We investigated the prevalence of pathogenic variants and genotype–phenotype correlations in Korean patients with BMAD. Methods A total of 69 patients with BMAD were retrospectively enrolled at Seoul National University Hospital (2009–2023). Whole-exome sequencing was performed for 35 patients. Clinical, biochemical, and imaging data were analyzed. Serum steroid profiling was conducted using liquid chromatography–tandem mass spectrometry (LC-MS/MS) to quantify 18 adrenal-derived steroids. Results The mean age of the cohort was 66.4 years, and 58% were male. Most had mild autonomous cortisol secretion (79.7%), and 15.9% had overt Cushing syndrome. Among the 35 patients who underwent genetic testing, 22.9% harbored pathogenic/likely pathogenic (P/LP) variants in ARMC5. P/LP ARMC5 variant carriers had lower BMI (25.0 vs 27.4 kg/m²), larger maximal tumor diameter (4.1 vs 2.7 cm), and greater total adrenal volume (19.8 vs 15.3 cm³). LC-MS/MS profiling revealed that P/LP ARMC5 carriers had significantly higher cortisol (153.1 vs 100.6 ng/mL), corticosterone (16.5 vs 1.3 ng/mL), and 18-hydroxycortisol concentrations (1.66 vs 0.66 ng/mL) (P0.05). Conclusion This study in a Korean cohort with BMAD showed that P/LP ARMC5 variants were present in 22.9% of the genetically investigated patients and were associated with more severe radiological and steroidogenic features. These findings underscore the importance of closely monitoring patients with BMAD who carry ARMC5 P/LP variants.
Park et al. (Thu,) reported a other. In Korean patients with BMAD, 22.9% had P/LP ARMC5 variants, associated with larger tumor size and significantly higher cortisol levels (153.1 vs 100.6 ng/mL).